Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease

Eye

Volumn 23, Issue 1, 2009, Pages 202-208

  Ban, Y ^a,b   Ogawa, Y ^a   Goto, E ^a,c   Uchino, M ^a   Terauchi, N ^a   Seki, M ^a   Nakaya, M ^a   Saiki, M ^a   Mori, T ^a   Okamoto, S ^a   Matsumoto, Y ^a   Dogru, M ^a,b   Shimazaki, J ^a,b   Tsubota, K ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c TSURUMI UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Chronic GVHD; Conjunctival fibrosis; Dry eye; Tear interference; Tear lipid layer

Indexed keywords

ADULT; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONJUNCTIVAL FIBROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY EYE; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; INTERFEROMETRY; MALE; MEIBOMIAN GLAND; OCULAR FIBROSIS; SCHIRMER TEST; STAINING; TEAR FILM;

EID: 58249116632     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.340     Document Type: Article

References (23)

1. Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105-1111.
2. Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111-119.
3. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125-1130.
4. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-vs-host disease. Bone Marrow Transplant 2003; 31: 579-583.
5. Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Okamoto S, Tsubota K et al. Dry eye associated with chronic graft-vs-host disease. Adv Exp Med Biol 2002; 506(part B): 1041-1045.
6. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-vs-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22(7 Suppl): S19-S27.
7. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol 1996; 122: 818-824.
8. Suzuki S, Goto E, Dogru M, Asano-Kato N, Matsumoto Y, Hara Y et al. Tear film lipid layer alterations in allergic conjunctivitis. Cornea 2006; 25: 277-280.
9. Yokoi N, Komuro A. Non-invasive methods of assessing the tear film. Exp Eye Res 2004; 78: 399-407.
10. Goto E, Tseng SC. Differentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference images. Arch Ophthalmol 2003; 121: 173-180.
11. Goto E. Quantification of tear interference image: tear fluid surface nanotechnology. Cornea 2004; 23(8 Suppl): S20-S24.
12. Altinors DD, Akca S, Akova YA, Bilezikci B, Goto E, Dogru M et al. Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol 2006; 141: 1016-1021.
13. Lemp MA, Boudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S et al., Definition and Classification Subcommittee members: The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 75-92.
14. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993; 12: 366-367.
15. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 1994; 13: 202-209.
16. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K et al. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology 1998; 105: 1485-1488.
17. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-vs-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
18. Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-vs-host disease. Bone Marrow Transplant 2004; 33: 1031-1035.
19. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107: 1343-1348.
20. Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-vs-host disease. Bone Marrow Transplant 2008; 41: 293-302.
21. Amer J, Weiss L, Reich S, Shapira MY, Slavin S, Fibach E. The oxidative status of blood cells in a murine model of graft-vs-host disease. Ann Hematol 2007; 86: 753-758.
22. Katz D, Mazor D, Dvilansky A, Meyerstein N. Effect of radiation on red cell membrane and intracellular oxidative defense systems. Free Radic Res 1996; 24: 199-204.
23. Danjo Y, Hamano T. Observation of precorneal tear film in patients with Sjogren's syndrome. Acta Ophthalmol Scand 1995; 73: 501-505.